Home / Services / By Technology / DNA and RNA Synthesis Services / Custom DNA Synthesis / Gene Synthesis Service / Antibody gene synthesis service
Antibody Gene Synthesis

Rapid Synthesis & Cloning of Antibody Heavy and Light Chain Sequences

Accelerate your antibody discovery pipeline with precision gene synthesis tailored for therapeutic and research applications.

Our antibody gene synthesis service delivers sequence-verified, custom-cloned heavy and light chain DNA constructs in as little as 6 days. Optimize your antibody expression with codon optimization, any custom vector, and rigorous QC — all designed to support your downstream protein production and functional studies.

  • 100% sequence-verified clonal DNA
  • Custom vector construction for any expression system
  • Codon optimization for mammalian, E. coli, or yeast hosts
  • Rapid turnaround from sequence submission to lyophilized DNA

Service Highlights

End-to-end support from sequence optimization to final clone.

  • Synthesis and cloning of heavy and light chain genes
  • Any custom vector accepted
  • Sequence verification by Sanger sequencing
  • Lyophilized DNA and glycerol stock deliverables
Therapeutic antibody discovery
Hybridoma & phage display projects
Recombinant antibody production
Why Antibody Gene Synthesis?

Precision DNA Construction for Next-Generation Antibodies

Antibody sequence optimization and vector construction are critical for efficient expression and functional activity. Our service provides the exact DNA constructs you need to move from candidate to characterization.

Complete Synthesis & Cloning

We synthesize your antibody heavy and light chain variable regions (VH, VL) and clone them into your chosen expression vector. Whether you need single-chain variable fragments (scFv), Fab fragments, or full-length IgG, we deliver sequence-verified plasmid DNA ready for transfection.

  • Synthesis of VH, VL, full-length heavy and light chains
  • Cloning into any custom vector (mammalian, bacterial, yeast)
  • 100% sequence verification by Sanger

Sequence Optimization

Codon optimization can enhance expression levels in your host system. We analyze and optimize your antibody gene sequences to match the codon bias of CHO, HEK293, E. coli, or other expression hosts, while preserving the encoded amino acid sequence.

  • Codon optimization for mammalian, E. coli, yeast
  • Removal of cryptic splice sites and rare codons
  • GC content and secondary structure balancing

Therapeutic Antibody Development

Generate high-quality DNA constructs for lead candidate expression, screening, and optimization.

  • Synthesis of multiple variants (e.g., affinity maturation)
  • Compatible with transient and stable expression systems

Diagnostic & Research Reagents

Produce antibody genes for ELISA, Western blot, flow cytometry, and other immunoassays with consistent quality.

  • Custom epitope tags and linkers included
  • Small-scale and large-scale production options

Hybridoma & Phage Display Output

Convert hybridoma or phage display-derived sequences into expression-ready constructs for recombinant production.

  • Direct cloning from hybridoma or phage display vectors
  • Humanization or chimerization services available
Technology & Workflow

How We Deliver Your Antibody Genes

Our process integrates advanced synthesis chemistry, automated cloning, and rigorous quality control to ensure every construct meets your specifications.

Sequence Submission & Optimization

Provide your antibody heavy and light chain sequences (or those of your variable regions). We perform codon optimization and eliminate problematic motifs while preserving the native amino acid sequence.

Codon Optimization
  • Human, mouse, CHO, HEK293, E. coli, yeast codon tables
  • GC content optimization to avoid secondary structure
Sequence Analysis
  • Removal of internal restriction sites and repeats
  • Prediction of mRNA stability and translation efficiency

Gene Synthesis & Cloning

We synthesize the optimized DNA sequences using high-fidelity enzymatic synthesis and clone them into your chosen vector. Simultaneous synthesis of both heavy and light chain constructs is available.

Synthesis
  • High-fidelity, error-free synthesis for up to 3 kb
  • Parallel synthesis of multiple constructs
Cloning
  • Any custom vector accepted (mammalian, lentiviral, bacterial)
  • Restriction enzyme or Gibson Assembly® compatible

Quality Control & Delivery

Every clone is sequence-verified to 100% accuracy. We provide lyophilized DNA, glycerol stock, and full documentation including sequencing chromatograms.

Sequence Verification
  • Full-length Sanger sequencing of both strands
  • Alignment report confirming 100% identity
Deliverables
  • Lyophilized plasmid DNA (≥4 µg)
  • Glycerol stock of E. coli clone
  • Electronic sequence and QC data

Supported Expression Systems

  • Mammalian (CHO, HEK293, NS0, SP2/0)
  • E. coli (periplasmic expression)
  • Yeast (P. pastoris, S. cerevisiae)
  • Insect cell (baculovirus)

Customizable Options

  • Signal peptide optimization
  • Epitope tags (His, HA, FLAG, Myc, etc.)
  • Flexible linker sequences for scFv or bispecific formats
  • Multiple cloning site variations
Comparison

Antibody Gene Synthesis Service vs. Traditional Cloning

Our service eliminates the time-consuming steps of PCR amplification, restriction digestion, and ligation, delivering sequence-verified constructs in a fraction of the time.

Feature Our Antibody Gene Synthesis Service Traditional Cloning from cDNA
Turnaround Time As few as 6 days for standard constructs 2–4 weeks typically
Sequence Verification 100% sequence-verified by Sanger Often limited to restriction digest or partial sequencing
Codon Optimization Included for any host system Not available
Custom Vector Cloning Any vector accepted Limited to vector with compatible restriction sites
Multiple Constructs Parallel synthesis of heavy and light chains Sequential cloning required
Error-Free Synthesis Enzymatic synthesis with proofreading PCR errors possible
Workflow

From Sequence to Clone in a Few Simple Steps

Our streamlined process ensures you receive sequence-verified antibody gene constructs without unnecessary delays.

1. Submit Sequences

Provide your antibody heavy and light chain sequences (or variable regions) via our online portal. Include your desired vector, expression host, and any special requirements (e.g., tags, linkers).

2. Sequence Optimization

Our team analyzes your sequences for codon optimization, removes problematic motifs, and ensures compatibility with your chosen expression system. You receive an optimization report for approval.

3. Synthesis & Cloning

We synthesize the optimized DNA using high-fidelity enzymatic synthesis and clone it into your chosen vector. Both heavy and light chain constructs are processed simultaneously.

4. Quality Control

Every clone undergoes full-length Sanger sequencing of both strands. We verify 100% sequence identity and provide an alignment report. Only clones passing QC are released.

5. Delivery

You receive lyophilized plasmid DNA, a glycerol stock of the transformed E. coli clone, and electronic data including sequencing chromatograms and QC certificates.

Applications

Where Antibody Gene Synthesis Makes a Difference

From therapeutic discovery to diagnostic reagent production, our service supports a wide range of antibody development workflows.

Accelerate Lead Candidate Generation

In therapeutic antibody development, speed and accuracy are paramount. Our gene synthesis service enables you to quickly convert hybridoma-derived sequences, phage display outputs, or in silico-designed antibodies into expression-ready constructs. Codon optimization for CHO or HEK293 cells can improve expression yields, while simultaneous synthesis of heavy and light chain genes reduces the time from candidate identification to functional testing.

  • Parallel synthesis of heavy and light chains for IgG, scFv, Fab
  • Codon optimization for mammalian expression systems
  • Compatible with transient and stable cell line generation

Reliable DNA for Research Reagents

  • Single-vector or dual-vector expression systems
  • Custom tags (His, Fc, FLAG) for purification
  • Small-scale to large-scale synthesis options

Rapid Cloning for Assay Development

  • Direct cloning from hybridoma or single-cell PCR
  • Optimization for E. coli or mammalian expression
  • Sequence verification eliminates cloning errors
FAQ

Antibody Gene Synthesis — Common Questions

Find answers to frequently asked questions about our service, including turnaround, sequence requirements, and customization options.

  • We synthesize antibody gene fragments from as small as 100 bp up to 3 kb. For typical antibody variable regions (VH, VL ~350 bp each) or full-length heavy and light chains (1.5–2 kb), our synthesis process is fully compatible. If you need larger constructs, please contact us to discuss options.

  • Yes, we accept any custom vector you provide. We can clone your antibody gene using restriction enzyme-based or Gibson Assembly® methods. Please provide at least 1 µg of purified vector DNA and a sequence map. We will confirm compatibility before proceeding.

  • Yes, codon optimization is included in our service. We analyze your antibody sequence and optimize it for the expression host you specify (e.g., CHO, HEK293, E. coli, yeast). The optimization preserves the amino acid sequence while removing rare codons, cryptic splice sites, and secondary structures that could reduce expression.

  • Every clone is verified by full-length Sanger sequencing of both strands. We compare the sequencing data to the reference sequence and provide an alignment report confirming 100% sequence identity. Only clones that pass this rigorous QC are shipped.

Scientific Literature

References

  1. Ganesh K, Neuberger MS. The relationship between hypothesis and experiment in unveiling the mechanisms of antibody gene diversification. FASEB J 2011 Apr. PubMed
  2. Willis JR, Briney BS, DeLuca SL. Human germline antibody gene segments encode polyspecific antibodies. PLoS Comput Biol 2013 Apr. PubMed
  3. Hsia HE, Zanini C, Simonneau C. Improved targeted delivery of antisense oligonucleotide with an antibody mask. Nucleic Acids Res 2025 Oct 28. PubMed
  4. Zhou X, Ma F, Xie J. Diverse immunoglobulin gene usage and convergent epitope targeting in neutralizing antibody responses to SARS-CoV-2. Cell Rep 2021 May 11. PubMed
  5. Brücher D, Franc V, Smith SN. Malignant tissues produce divergent antibody glycosylation of relevance for cancer gene therapy effectiveness. MAbs 2020 Jan-Dec. PubMed

Ready to Start Your Project?

Get a customized quote for your Antibody gene synthesis service project. Our experts will respond within 24 hours.

No obligation
24h response
Expert consultation
Get a free quote

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.